These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34894851)

  • 21. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients.
    Elkaraly NE; Nasef SI; Omar AS; Fouad AM; Jolly M; Mohamed AE
    Lupus; 2020 Nov; 29(13):1727-1735. PubMed ID: 32878556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the systemic lupus erythematosus activity questionnaire and the systemic lupus erythematosus disease activity index in a black barbadian population.
    Quimby KR; Flower C; Hambleton IR; Landis RC; Hennis AJ
    Int J Rheumatol; 2013; 2013():875369. PubMed ID: 24282416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
    Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).
    Rendas-Baum R; Baranwal N; Joshi AV; Park J; Kosinski M
    J Patient Rep Outcomes; 2021 Apr; 5(1):33. PubMed ID: 33830377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Modified Fatigue Impact Scale in patients with systemic lupus erythematosus.
    Junker CI; Dreyer L; Duch K; Waarst Gregersen J; Kristensen S
    Lupus; 2022 Nov; 31(13):1572-1577. PubMed ID: 36120945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus.
    Bae SC; Koh HK; Chang DK; Kim MH; Park JK; Kim SY
    Lupus; 2001; 10(6):405-9. PubMed ID: 11434575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric validation of the Brief Pain Inventory-Short Form in patients with systemic lupus erythematosus in the United States.
    Naegeli AN; Tomaszewski EL; Al Sawah S
    Lupus; 2015 Nov; 24(13):1377-83. PubMed ID: 26038345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study.
    Horisberger A; Courvoisier D; Ribi C
    Arthritis Res Ther; 2019 Mar; 21(1):80. PubMed ID: 30909957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability and validity of the Chinese version of the eight-item Morisky Medication Adherence Scale in Chinese patients with systemic lupus erythematosus.
    Shi PL; Wu ZZ; Wu L; Gao RC; Wu ZG; Wu GC
    Clin Rheumatol; 2022 Sep; 41(9):2713-2720. PubMed ID: 35536414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Japanese version of the Lupus Damage Index Questionnaire in a large observational cohort: A two-year prospective study.
    Okamoto Y; Katsumata Y; Baba S; Kawaguchi Y; Harigai M
    Mod Rheumatol; 2021 Jul; 31(4):834-842. PubMed ID: 32990111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.
    Chang E; Abrahamowicz M; Ferland D; Fortin PR;
    J Clin Epidemiol; 2002 May; 55(5):488-97. PubMed ID: 12007552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2017 Jul; 44(7):1024-1031. PubMed ID: 28412708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus.
    Mattsson M; Möller B; Lundberg Ie; Gard G; Boström C
    Scand J Rheumatol; 2008; 37(4):269-77. PubMed ID: 18612927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptation and validation of the Bulgarian version of the Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL).
    Pencheva DT; Coffey A; McKenna SP; Monov SV
    Clin Rheumatol; 2023 Jul; 42(7):1811-1817. PubMed ID: 36913029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus.
    Jolly M; Kosinski M; Garris CP; Oglesby AK
    Arthritis Rheumatol; 2016 Jun; 68(6):1422-31. PubMed ID: 26814452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.
    Fatemi A; Raeisi A; Sayedbonakdar Z; Smiley A
    Clin Rheumatol; 2018 Apr; 37(4):955-962. PubMed ID: 29256112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.